MedPath

Indobufen

Generic Name
Indobufen
Drug Type
Small Molecule
Chemical Formula
C18H17NO3
CAS Number
63610-08-2
Unique Ingredient Identifier
6T9949G4LZ

Overview

Indobufen has been used in trials studying the supportive care and prevention of Atrial Fibrillation.

Indication

用于动脉硬化引起的缺血性心血管病变、缺血性脑血管病变、静脉血栓形成。也可用于血液透析时预防血栓形成。

Associated Conditions

  • Platelet Aggregation

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Indobufen Tablets
国药准字H20253400
化学药品
片剂
2/20/2025
Indobufen Tablets
国药准字H20253399
化学药品
片剂
2/20/2025
Indobufen Tablets
国药准字H20253852
化学药品
片剂
4/8/2025
Indobufen Tablets
国药准字H20253943
化学药品
片剂
4/15/2025
Indobufen Tablets
国药准字H20244297
化学药品
片剂
6/28/2024
Indobufen Tablets
国药准字H20249478
化学药品
片剂
12/1/2024
Indobufen Tablets
国药准字H20244933
化学药品
片剂
9/19/2024
Indobufen Tablets
国药准字H20244906
化学药品
片剂
9/19/2024
Indobufen Tablets
国药准字H20243075
化学药品
片剂
1/23/2024
Indobufen Tablets
国药准字H20244907
化学药品
片剂
9/19/2024

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath